RetinaVue Diabetic Screening

Status unconfirmed · Not applicable

Conditions studied: Diabetic Retinopathy

In brief

the purpose of this study is to examine whether the deployment of a non-mydriatic color fundus camera in a rural prime care setting is feasible and improves the detection rate of diabetic retinopathy in patients where adherence rates with recommended ophthalmology screening is low.

Key facts

Study ID

NCT03343730

Run by

Bassett Healthcare

People needed

50

Starts

2018-02-27

Expected to finish

2018-10-01

Last updated by the study team

2018-07-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years
• Type II diabetes without documented diabetic retinopathy

You may not qualify if…

• Documented ocular pathology that may interfere with image acquisition (i.e. high grade cataract)
• Macular pathology (i.e. macular degeneration, cystoid macular edema, central serous retinopathy)
• Inability to attain analyzable RetinaVue image due to ocular pathology or other conditions (such as tremors limiting ability to maintain stable head for image)
• Acute or emergent ocular pathology that requires urgent assessment by an eye care professional as identified by the RetinaVue camera interpretation report
• Seen within the last 11 months for a diabetic eye exam.

Where it is running

• Bassett Medical Center — Cooperstown, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.